{"id":8156,"date":"2016-03-12T13:34:52","date_gmt":"2016-03-12T12:34:52","guid":{"rendered":"https:\/\/staging.futurehealthbiobank.com\/si\/?p=8156"},"modified":"2018-01-15T13:35:37","modified_gmt":"2018-01-15T12:35:37","slug":"prva-studija-za-hiv","status":"publish","type":"post","link":"https:\/\/staging.futurehealthbiobank.com\/si\/blog\/prva-studija-za-hiv\/","title":{"rendered":"Prva \u0161tudija za HIV"},"content":{"rendered":"

Prva klini\u010dna \u0161tudija na svetu, da razi\u0161\u010de mo\u017enosti ,zdravljenje z mati\u010dnimi celicami pri oku\u017ebi z virusom HIV za\u010dela se bo zgodaj prihodnje leto v \u0160paniji.<\/p>\n

Timothy Ray Brown so \u017eal diagnosticirali levkemijo v letu 2006 in potrebo po presaditvi za zdravljenje raka. Zdravnik je se je odlo\u010dil za zdravljenje z mati\u010dnm celicam darovalca z dolo\u010deno celi\u010dno mutacijo, zaradi katere so celice odporne na virus HIV. Kasneje je Brown prejel \u0161e dve presaditvi mati\u010dnih celicod darovalca kostnega mozga, njegova raven HIVa se je mo\u010dno zmanj\u0161ala. Sedaj je brez raka in je mogo\u010de najti sledi virusa, vendar pa se ne morejo razmno\u017eevati.<\/p>\n

Timothy Ray Brown so \u017eal diagnosticirali levkemijo v letu 2006 in potrebo po presaditvi za zdravljenje raka. Zdravnik je se je odlo\u010dil za zdravljenje z mati\u010dnm celicam darovalca z dolo\u010deno celi\u010dno mutacijo, zaradi katere so celice odporne na virus HIV. Kasneje je Brown prejel \u0161e dve presaditvi mati\u010dnih celicod darovalca kostnega mozga, njegova raven HIVa se je mo\u010dno zmanj\u0161ala. Sedaj je brez raka in je mogo\u010de najti sledi virusa, vendar pa se ne morejo razmno\u017eevati.<\/p>\n

Na\u010drti za klini\u010dno presku\u0161anje so objavili na hematolo\u0161ki konferenci v Valencii, ki ga organizira nacionalna organizacija za transplatacije\u0160panija (ONT). ONT je izbrala 157 darovalcev popkovni\u010dne krvi, ki so genetsko mutirani in jim omogo\u010da, da se uprejo HIV u. Pripravili na\u010drti za zdravljenje petih HIV pozitivnih bolnikov, ki imajo tudi raka, kot je levkemijo ali limfomom, podobno tistemu v Berlinu Pacient.<\/p>\n

Zdravniki upajo, da za\u010dnejo svojo prvo klini\u010dno \u0161tudijo med decembrom 2015 in januarjem 2016 v Madridu, \u0160panija.<\/p>\n","protected":false},"excerpt":{"rendered":"

Prva klini\u010dna \u0161tudija na svetu, da razi\u0161\u010de mo\u017enosti ,zdravljenje z mati\u010dnimi celicami pri oku\u017ebi z virusom HIV za\u010dela se bo zgodaj prihodnje leto v \u0160paniji.<\/p>\n","protected":false},"author":25,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[218],"tags":[],"class_list":["post-8156","post","type-post","status-publish","format-standard","hentry","category-klinicne-posodobitve"],"acf":[],"yoast_head":"\nPrva \u0161tudija za HIV - Future Health Biobank Slovenia<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"sl_SI\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Prva \u0161tudija za HIV - Future Health Biobank Slovenia\" \/>\n<meta property=\"og:description\" content=\"Prva klini\u010dna \u0161tudija na svetu, da razi\u0161\u010de mo\u017enosti ,zdravljenje z mati\u010dnimi celicami pri oku\u017ebi z virusom HIV za\u010dela se bo zgodaj prihodnje leto v \u0160paniji.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/staging.futurehealthbiobank.com\/si\/blog\/prva-studija-za-hiv\/\" \/>\n<meta property=\"og:site_name\" content=\"Future Health Biobank Slovenia\" \/>\n<meta property=\"article:published_time\" content=\"2016-03-12T12:34:52+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-01-15T12:35:37+00:00\" \/>\n<meta name=\"author\" content=\"jwhybrow\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"jwhybrow\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuta\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/staging.futurehealthbiobank.com\/si\/blog\/prva-studija-za-hiv\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/staging.futurehealthbiobank.com\/si\/blog\/prva-studija-za-hiv\/\"},\"author\":{\"name\":\"jwhybrow\",\"@id\":\"https:\/\/staging.futurehealthbiobank.com\/si\/#\/schema\/person\/7232eecb00f5f56f8f268c5ff3db6719\"},\"headline\":\"Prva \u0161tudija za HIV\",\"datePublished\":\"2016-03-12T12:34:52+00:00\",\"dateModified\":\"2018-01-15T12:35:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/staging.futurehealthbiobank.com\/si\/blog\/prva-studija-za-hiv\/\"},\"wordCount\":285,\"commentCount\":0,\"articleSection\":[\"Klini\u010dne posodobitve\"],\"inLanguage\":\"sl-SI\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/staging.futurehealthbiobank.com\/si\/blog\/prva-studija-za-hiv\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/staging.futurehealthbiobank.com\/si\/blog\/prva-studija-za-hiv\/\",\"url\":\"https:\/\/staging.futurehealthbiobank.com\/si\/blog\/prva-studija-za-hiv\/\",\"name\":\"Prva \u0161tudija za HIV - Future Health Biobank Slovenia\",\"isPartOf\":{\"@id\":\"https:\/\/staging.futurehealthbiobank.com\/si\/#website\"},\"datePublished\":\"2016-03-12T12:34:52+00:00\",\"dateModified\":\"2018-01-15T12:35:37+00:00\",\"author\":{\"@id\":\"https:\/\/staging.futurehealthbiobank.com\/si\/#\/schema\/person\/7232eecb00f5f56f8f268c5ff3db6719\"},\"inLanguage\":\"sl-SI\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/staging.futurehealthbiobank.com\/si\/blog\/prva-studija-za-hiv\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.futurehealthbiobank.com\/si\/#website\",\"url\":\"https:\/\/staging.futurehealthbiobank.com\/si\/\",\"name\":\"Future Health Biobank Slovenia\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.futurehealthbiobank.com\/si\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sl-SI\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.futurehealthbiobank.com\/si\/#\/schema\/person\/7232eecb00f5f56f8f268c5ff3db6719\",\"name\":\"jwhybrow\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sl-SI\",\"@id\":\"https:\/\/staging.futurehealthbiobank.com\/si\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a281433b62a053423a023cad7e2a5257?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a281433b62a053423a023cad7e2a5257?s=96&d=mm&r=g\",\"caption\":\"jwhybrow\"},\"url\":\"https:\/\/staging.futurehealthbiobank.com\/si\/blog\/author\/jwhybrow\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Prva \u0161tudija za HIV - Future Health Biobank Slovenia","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"sl_SI","og_type":"article","og_title":"Prva \u0161tudija za HIV - Future Health Biobank Slovenia","og_description":"Prva klini\u010dna \u0161tudija na svetu, da razi\u0161\u010de mo\u017enosti ,zdravljenje z mati\u010dnimi celicami pri oku\u017ebi z virusom HIV za\u010dela se bo zgodaj prihodnje leto v \u0160paniji.","og_url":"https:\/\/staging.futurehealthbiobank.com\/si\/blog\/prva-studija-za-hiv\/","og_site_name":"Future Health Biobank Slovenia","article_published_time":"2016-03-12T12:34:52+00:00","article_modified_time":"2018-01-15T12:35:37+00:00","author":"jwhybrow","twitter_card":"summary_large_image","twitter_misc":{"Written by":"jwhybrow","Est. reading time":"1 minuta"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/staging.futurehealthbiobank.com\/si\/blog\/prva-studija-za-hiv\/#article","isPartOf":{"@id":"https:\/\/staging.futurehealthbiobank.com\/si\/blog\/prva-studija-za-hiv\/"},"author":{"name":"jwhybrow","@id":"https:\/\/staging.futurehealthbiobank.com\/si\/#\/schema\/person\/7232eecb00f5f56f8f268c5ff3db6719"},"headline":"Prva \u0161tudija za HIV","datePublished":"2016-03-12T12:34:52+00:00","dateModified":"2018-01-15T12:35:37+00:00","mainEntityOfPage":{"@id":"https:\/\/staging.futurehealthbiobank.com\/si\/blog\/prva-studija-za-hiv\/"},"wordCount":285,"commentCount":0,"articleSection":["Klini\u010dne posodobitve"],"inLanguage":"sl-SI","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/staging.futurehealthbiobank.com\/si\/blog\/prva-studija-za-hiv\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/staging.futurehealthbiobank.com\/si\/blog\/prva-studija-za-hiv\/","url":"https:\/\/staging.futurehealthbiobank.com\/si\/blog\/prva-studija-za-hiv\/","name":"Prva \u0161tudija za HIV - Future Health Biobank Slovenia","isPartOf":{"@id":"https:\/\/staging.futurehealthbiobank.com\/si\/#website"},"datePublished":"2016-03-12T12:34:52+00:00","dateModified":"2018-01-15T12:35:37+00:00","author":{"@id":"https:\/\/staging.futurehealthbiobank.com\/si\/#\/schema\/person\/7232eecb00f5f56f8f268c5ff3db6719"},"inLanguage":"sl-SI","potentialAction":[{"@type":"ReadAction","target":["https:\/\/staging.futurehealthbiobank.com\/si\/blog\/prva-studija-za-hiv\/"]}]},{"@type":"WebSite","@id":"https:\/\/staging.futurehealthbiobank.com\/si\/#website","url":"https:\/\/staging.futurehealthbiobank.com\/si\/","name":"Future Health Biobank Slovenia","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.futurehealthbiobank.com\/si\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sl-SI"},{"@type":"Person","@id":"https:\/\/staging.futurehealthbiobank.com\/si\/#\/schema\/person\/7232eecb00f5f56f8f268c5ff3db6719","name":"jwhybrow","image":{"@type":"ImageObject","inLanguage":"sl-SI","@id":"https:\/\/staging.futurehealthbiobank.com\/si\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/a281433b62a053423a023cad7e2a5257?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a281433b62a053423a023cad7e2a5257?s=96&d=mm&r=g","caption":"jwhybrow"},"url":"https:\/\/staging.futurehealthbiobank.com\/si\/blog\/author\/jwhybrow\/"}]}},"_links":{"self":[{"href":"https:\/\/staging.futurehealthbiobank.com\/si\/wp-json\/wp\/v2\/posts\/8156","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/staging.futurehealthbiobank.com\/si\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/staging.futurehealthbiobank.com\/si\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/staging.futurehealthbiobank.com\/si\/wp-json\/wp\/v2\/users\/25"}],"replies":[{"embeddable":true,"href":"https:\/\/staging.futurehealthbiobank.com\/si\/wp-json\/wp\/v2\/comments?post=8156"}],"version-history":[{"count":0,"href":"https:\/\/staging.futurehealthbiobank.com\/si\/wp-json\/wp\/v2\/posts\/8156\/revisions"}],"wp:attachment":[{"href":"https:\/\/staging.futurehealthbiobank.com\/si\/wp-json\/wp\/v2\/media?parent=8156"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/staging.futurehealthbiobank.com\/si\/wp-json\/wp\/v2\/categories?post=8156"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/staging.futurehealthbiobank.com\/si\/wp-json\/wp\/v2\/tags?post=8156"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}